Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Corporation stock logo
CNMD
CONMED
$53.62
-1.5%
$52.20
$46.00
$78.19
$1.66B1.17476,368 shs133,365 shs
Enovis Corporation stock logo
ENOV
Enovis
$30.32
-2.2%
$30.05
$25.47
$49.83
$1.73B1.71.19 million shs668,444 shs
NovoCure Limited stock logo
NVCR
NovoCure
$11.95
+0.3%
$14.41
$10.87
$34.13
$1.33B0.611.22 million shs934,085 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$7.40
-0.3%
$6.15
$4.54
$10.79
$468.41M0.68395,348 shs127,206 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Corporation stock logo
CNMD
CONMED
-0.41%+1.75%+8.73%-5.54%-25.06%
Enovis Corporation stock logo
ENOV
Enovis
-0.38%+3.61%+13.59%-2.95%-31.70%
NovoCure Limited stock logo
NVCR
NovoCure
+0.68%+1.10%+2.32%-38.61%-33.83%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-0.27%+3.92%+29.04%+26.62%+20.85%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Corporation stock logo
CNMD
CONMED
4.4006 of 5 stars
2.12.02.54.33.10.03.1
Enovis Corporation stock logo
ENOV
Enovis
4.5366 of 5 stars
4.53.00.00.04.13.31.9
NovoCure Limited stock logo
NVCR
NovoCure
4.1445 of 5 stars
3.32.00.04.53.13.30.0
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.4462 of 5 stars
3.21.00.00.02.93.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Corporation stock logo
CNMD
CONMED
2.20
Hold$59.8011.53% Upside
Enovis Corporation stock logo
ENOV
Enovis
3.00
Buy$51.0068.18% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.57
Moderate Buy$28.79140.99% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.33
Hold$9.8332.97% Upside

Current Analyst Ratings Breakdown

Latest TMCI, ENOV, CNMD, and NVCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $58.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $57.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$48.00 ➝ $41.00
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$8.60 ➝ $6.50
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.00 ➝ $6.00
8/7/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.00 ➝ $49.00
7/31/2025
CONMED Corporation stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $68.00
7/25/2025
NovoCure Limited stock logo
NVCR
NovoCure
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$40.00 ➝ $14.50
7/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$48.00 ➝ $46.00
7/8/2025
NovoCure Limited stock logo
NVCR
NovoCure
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
6/27/2025
NovoCure Limited stock logo
NVCR
NovoCure
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$34.00
(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.27$6.58 per share8.15$32.40 per share1.65
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.82$18.72 per share1.62$45.15 per share0.67
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M2.21N/AN/A$3.13 per share3.82
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$209.36M2.23N/AN/A$1.55 per share4.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5315.1910.581.868.31%14.43%6.05%10/29/2025 (Estimated)
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$14.25N/A9.51N/A-37.80%6.78%3.73%11/5/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/29/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$55.74M-$0.79N/AN/AN/A-23.01%-46.76%-23.35%11/4/2025 (Estimated)

Latest TMCI, ENOV, CNMD, and NVCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.79+$0.05-$0.64$555.80 million$564.50 million
8/7/2025Q2 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.29-$0.28+$0.01-$0.28$47.08 million$47.39 million
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Corporation stock logo
CNMD
CONMED
$0.801.49%N/A22.66%N/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A

Latest TMCI, ENOV, CNMD, and NVCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.5%9/15/20259/15/202510/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Corporation stock logo
CNMD
CONMED
0.88
2.23
1.00
Enovis Corporation stock logo
ENOV
Enovis
0.53
2.25
1.15
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.55
3.52
2.51

Institutional Ownership

CompanyInstitutional Ownership
CONMED Corporation stock logo
CNMD
CONMED
N/A
Enovis Corporation stock logo
ENOV
Enovis
98.45%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
CONMED Corporation stock logo
CNMD
CONMED
3.10%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.95 million30.00 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.16 million55.62 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25063.17 million45.66 millionOptionable

Recent News About These Companies

Treace Medical (TMCI) Q2 Revenue Up 7%

New MarketBeat Followers Over Time

Media Sentiment Over Time

CONMED stock logo

CONMED NYSE:CNMD

$53.62 -0.81 (-1.49%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis stock logo

Enovis NYSE:ENOV

$30.32 -0.70 (-2.24%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$11.94 +0.04 (+0.29%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$7.40 -0.03 (-0.34%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.